HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dr. King's Homeopathics Recalled; MyNicNaxs Starts Recall 3 Months After FDA Shutdown

This article was originally published in The Rose Sheet

Executive Summary

Dr. King's brand homeopathic Aquaflora Candida HP9, Lymph Detox and Baby Teething liquids are recalled after FDA found microbial contaminants. MyNicNaxs, which was shut down in March, is recalling all supplements it sold for five years. Gaia Ethnobotanical is latest firm recalling kratom-containing supplements due to salmonella.

You may also be interested in...



King Bio Recalls Due To Potential Microbial Contamination Approach 500

FDA deemed 469 homeopathic remedies manufactured by King Bio – marketed as Dr. King’s: Natural Medicine, Aquaflora, SafeCareRx and Safecare bands – and recalled since July as class I, indicating the agency considers that a violative product poses reasonable probability of serious adverse health consequences or death. Kingston Pharma recalls one lot of DG/health Naturals baby Cough Syrup + Mucus potentially contaminated and Ata Int.'s BlueFusion product marketed as a dietary supplement contains ED ingredients and other drugs.

FDA Gets Final With Guidance On Recall Public Warnings, Notifications

There may be fewer recalls, but they are getting more publicity, in part because of FDA warnings that one recalcitrant firm said “decimated” sales.

Health, Beauty And Wellness News: Nature's Bounty Appointment, Healthy Healing Warning, Recalls

Related Content

Topics

UsernamePublicRestriction

Register

RS121736

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel